Scientists have discovered a link between mutated mitochondria in cancer patients and a successful response to immunotherapy, signaling a new potential treatment.
According to a new study published in Nature Cancer, nearly half of all cancer patients have mitochondria with DNA mutations. The mutations are a blessing of sorts, as they help the body respond to immunotherapy, a type of cancer treatment. In fact, the treatment can be significantly more effective when mitochondria are defective.
